Novartis | NOVN - PE Price to Earnings

Stock Price
102.32
Daily Change
-1.66 -1.60%
Monthly
6.56%
Yearly
2.73%
Q3 Forecast
103.29

Novartis reported $15.89 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie USD 18.41 69.26 Jun/2025
Alcon AG USD 39.04 7.04 Jun/2025
Almirall EUR 79.13 120.6 Jun/2025
Amgen USD 12.51 28.7 Jun/2025
AstraZeneca USD 20.04 12.31 Jun/2025
Bayer EUR 6.61 1.6 Jun/2025
Biogen USD 12.41 0.17 Jun/2025
Bristol-Myers Squibb USD 17.27 3.22 Jun/2025
Eli Lilly USD 37 7.55 Jun/2025
Fresenius EUR 22.82 1.17 Jun/2025
Fresenius Medical Care EUR 11.22 13.68 Jun/2025
Galapagos EUR 53.92 0 Mar/2025
Genmab DKK 12.13 1.06 Jun/2025
Gilead Sciences USD 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
GRIFOLS EUR 45 27.14 Jun/2025
Hikma Pharmaceutical USD 19.56 8.4 Jun/2024
J&J USD 19.02 9.62 Jun/2025
Lonza CHF 67.52 12.2 Jun/2024
Merck EUR 13.5 6.24 Jun/2025
Merck USD 8.58 4.74 Jun/2025
Novartis USD 15.89 3.03 Jun/2025
Novartis USD 18.97 1.99 Jun/2025
Novo Nordisk 17.47 3.29 Jun/2025
Orion EUR 21.59 1.75 Jun/2025
Pfizer USD 9.12 8.86 Jun/2025
Philips EUR 17.8 13.93 Jun/2025
Recordati EUR 26.71 0.47 Jun/2025
Regeneron Pharmaceuticals USD 13.35 3.19 Jun/2025
Roche Holding CHF 19.32 1.87 Jun/2024
Sanofi EUR 16.47 6.85 Jun/2025
UCB EUR 156.24 77.45 Jun/2024